Phillip Broadwith
As Business editor, my aim is to highlight to readers the exciting and innovative chemistry going on in the commercial sector, as well as keeping you abreast of trends and developments in the world of chemistry businesses.
From the point I left school, my aim was to join the pharmaceutical industry. A gap year and summer placements in company labs, and a PhD in organic synthesis followed.
But halfway through my PhD I entered a writing competition run by the Daily Telegraph. I managed to win – somewhat to my own surprise. That changed my perspective and made me think that I should consider writing more seriously as a career. I joined the Royal Society of Chemistry just before submitting my thesis, and luckily a position with Chemistry World came up a few months later. I sometimes miss the thrills (less so the spills) of lab work, but interacting with world-leading scientists and industrialists, as well as learning new things on a daily basis more than makes up for it.
BusinessChemical plant fire in Pakistan kills at least 17 workers
Blocked windows and exits hampered rescue efforts
- Business
Massive fire at UK polyurethanes plant
One worker remains missing a week after Leamington Spa incident
- Business
Deadly explosion and fire at chemicals park in Germany
At least 2 dead and 31 injured when an explosion led to a solvent tank fire in Leverkusen
- Business
BMS and Eisai agree antibody-drug conjugate commercialisation deal
Companies will jointly develop cancer treatment, with BMS paying up to $3 billion for shared rights
- Business
Morphosys agrees to buy cancer epigenetics specialist Constellation
$1.7bn deal will be funded by selling rights to royalties on existing drugs
- Business
Fatal explosion at US paint and polymers plant
One dead and nine others injured as building partially collapsed after explosion and fire
- Business
4 dead in UK sewage treatment works explosion
One person injured as biosolids silo explodes at Avonmouth
- Opinion
A promising peep at Covid-19 vaccine efficacy
Pfizer–BioNTech’s will need to be one of many if we are to overcome the pandemic
- Business
Innovation is a fragile transition state
Brexit and Covid-19 will likely stifle interactions, but could also stimulate new ones
- Opinion
Improving executive diversity is a priority
A few hiring decisions could make a big difference at leadership level
- Podcast
Sofosbuvir
The hepatitis C drug that made waves when first launched – quicker to work and with fewer side effects than existing drugs, but it came with a hefty price tag
- Opinion
Jumping the vaccine queue
Deals between companies and rich governments offset manufacturing risks, but must not compromise supplies to those in need
- Research
Options expanded for origin of Earth’s water
Enstatite chondrite meteroites contain enough hydrogen to have supplied three to five times the total mass of water in Earth’s oceans
- Opinion
Facing the challenge of vaccine trials
Russia’s Covid-19 gamble is a stark contrast to even accelerated clinical programmes
- Opinion
Looking beyond the next wave
We need to apply lessons from Covid-19 to tackle antimicrobial resistance and climate change
- Podcast
Book club – The Alchemy of Us by Ainissa Ramirez
Materials scientist Ainissa Ramirez’s new book uncovers the human side of world-changing inventions
- Opinion
Hopes and fears for remdesivir
Available resources for testing coronavirus treatments need to be used wisely
